Danish Head and Neck Cancer Group

Patient-Reported Outcomes in Head and Neck Cancer

Role: collaborator

Feasibility of Patient Selection and Treatment of Head-neck Cancer With Proton Therapy in Denmark

Role: lead

AF CRT +/- Nimorazole in HNSCC

Role: collaborator

DAHANCA 27 Transoral Laser Microsurgery for T1a Glottic Cancer

Role: lead

DAHANCA 30: A Randomized Non-inferiority Trial of Hypoxia-profile Guided Hypoxic Modification of Radiotherapy of HNSCC.

Role: lead

DAHANCA 35: Proton Versus Photon Therapy for Head-neck Cancer

Role: lead

DAHANCA 33: Image Guided Dose-escalated Radiotherapy to Patients With Hypoxic HNSCC

Role: lead

DAHANCA 37. Re-irradiation With Proton Radiotherapy

Role: lead

Progressive Resistance Training in Head and Neck Cancer Patients During Concomitant Chemoradiotherapy

Role: collaborator

Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor

Role: collaborator

DAHANCA 28A: Phase I/II Study on Accelerated, Hyperfractionated Radiotherapy With Concomitant Cisplatin and Nimorazole

Role: lead

DAHANCA 25A: Resistance Training and Dietary Supplements as Intervention for Regaining Muscle Mass Following Radiotherapy in Head and Neck Cancer Patients

Role: lead

DAHANCA 25B: Progressive Resistance Training as Intervention for Regaining Muscle Mass After Radiation Therapy in Patients With HNSCC

Role: lead

DAHANCA 19: The Importance of the EGFr-inhibitor Zalutumumab for the Outcome After Curative Radiotherapy for HNSCC

Role: lead

IAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and Neck

Role: lead

DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer

Role: collaborator

DAHANCA 24: Prognostic Value of 18F-FAZA in Head and Neck Squamous Cell Carcinoma (HNSCC)

Role: collaborator